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ABSTRACT 
While the entire human genome has been sequenced, the understanding of 
its functional elements remains unclear. The Encyclopedia of DNA Elements 
(ENCODE) project analyzed 1% of the human genome and found that the 
majority of the human genome is transcribed, including non-protein coding 
regions. The hypothesis is that some of the “non-coding” sequences are translated 
into peptides and small proteins. Using mass spectrometry numerous peptides 
derived from the ENCODE transcriptome were identified. Peptides and small 
proteins were also found from non-coding regions of the 1% of the human 
genome that the ENCODE did not find transcripts for. A large portion of these 
peptides mapped to the intronic regions of known genes, thus it is suspected that 
they may be undiscovered exons present in alternative spliceoforms of certain 
genes. Further studies proved the existence of polyadenylated RNAs coding for 
these peptides. Although their functional significance has not been determined, I 
anticipate the findings will lead to the discovery of new splice variants of known 
genes and possibly new transcriptional and translational mechanisms. 
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INTRODUCTION 
All the genetic information of an individual is encrypted in its DNA sequence, 
hence, whole genome sequencing is the foundation to study genes and their 
interactions which directly control the growth and development of an organism. It 
also facilitates the research on infectious diseases (Katalin & Kapranov, 2009), cancer 
biology (Mardis & Wilson, 2009) and agriculture improvement (Edwards & Batley, 
2010). Over the decades genome sequencing technologies have significantly increased 
throughput and reduced cost (Jiang, Rokhsar, & Harland, 2009). According to the 
statistical data from NCBI, the genomes of 832 organisms have been completely 
sequenced and this number will increase to roughly 2000 in the year 2012 (Chain et 
al., 2009; http://www.ncbi.nlm.nih.gov/genomes/static/gpstat.html). The human 
genome project (HGP), which was launched in 1990, was finished 2 years earlier with 
a highly accurate sequence of the vast majority of 2.85 billion nucleotides of the 
human genome (Collins, Lander, Rogers, Waterston, & Consortium, 2004; Lander et 
al., 2001). The challenge now is how to annotate the functional elements contained in 
the sequences. Experimental and computational methods have been developed to 
address the issue, but they are not quite satisfactory. Experimentally cloning all genes 
at present is both labor intensive and time consuming. Computational recognition 
programs, though more high-throughput, fail to provide accurate and reliable 
predictions (Frazer, Elnitski, Church, Dubchak, & Hardison, 2003), especially for 
eukaryotes because their genes are more complicated with intron-exon structures 
(Ratsch et al., 2007). In addition, all gene prediction programs are genome-dependent 
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and need experimental verification (Burge & Karlin, 1997). A thorough 
Gateway-cloning of all predicted protein-coding open reading frames (ORFs) of C. 
elegans shows that over 50% of the intron-exon structures needed corrections (Reboul 
et al., 2003). Here, we’ll demonstrate the combination of mass spectrometry of tumor 
cell surface elutions and some theoretical databases of human transcripts may assist 
gene annotation. 
Recent findings by the ENCODE pilot project revealed that at least 93% of the 
analyzed human genome are transcribed, including non-protein-coding sequences 
(Birney et al., 2007). The biological functions of non-protein-coding RNAs (ncRNA) 
are not well known yet, but they may play an important role in gene regulation 
(Amaral, Dinger, Mercer, & Mattick, 2008). Because the molecular machinery 
involved in protein synthesis is not fully understood, we propose that some of the 
ncRNAs may be translated. Using LC-MS/MS we identified numerous peptides 
encoded by the ENCODE RNAs. Further studies suggest there are polyadenylated 
RNAs encoding these peptides in some tumor cell lines and normal donor PBMCs. 
These peptides come from both intergenic and intronic regions of the human genome, 
suggesting they may be novel genes or undiscovered splice variants of known genes. 
Conservation of some of these non-exonic peptides suggests that whatever the 
mechanisms are that these peptides are translated, evolution chose to keep them for a 
reason. In addition, several non-exonic peptides are derived from different intronic 
regions of a tumor suppressor gene, suggesting there may be potential biomarkers for 
cancer diagnosis and even drug targets. In conclusion, with the detectable level of 
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peptides and small proteins from mass spectrometry and the existence of 
corresponding mRNA, we believe that non-exonic peptides are a starting point to 
examine new transcriptional and translational machineries and to identify genes, 
proteins, regulatory and structural elements. 
MATERIALS AND METHODS 
Cell lines and Cell Culture 
Table 1 
Cell Lines Used in the Discovery of ENCODE Peptides 
Cell name ATCC number Human Cell type 
A549 CCL-185 Lung carcinoma 
BXPC-3 CRL-1687 Pancreas adnocarcinoma 
DU-145 HTB-81 Prostate carcinoma 
MCF-7 HTB-22 Breast adenocarcinoma 
Panc-1 CRL-1469 Pancreas epitheloid carcinoma 
PMBC NA Human Peripheral blood mononuclear cells 
Tumor cells were grown in DMEM (Cellgro) supplemented with 10% 
heat-inactivated fetal bovine serum (FBS), 1000 U/ml penicillin-streptomycin, and 2 
mM L-glutamine. Peripheral blood mononuclear cells (PBMC) were purified from 
blood samples of normal donors by density centrifugation with Ficoll Hypaque. 
Acid Elution, 3 kDa Filtration and LC-MS/MS 
1x10
8
 cells of each tumor cell line A549 (lung), BXPC-3 (pancreas), DU145 
(prostate), MCF-7 (breast), and Panc-1 (pancreas) were harvested with Cellstripper 
 4 
 
(Mediatech Inc.), a non-enzymatic cell disassociation solution. Cells were centrifuged 
at 1000 rpm for 5 minutes and washed in 45 ml phosphate-buffered saline (PBS) for 3 
times. The cells were then resuspended in 1 ml citric acid buffer (pH 3.0) for 15 
minutes followed by 2-minute centrifugation. The supernatant was collected, 
immediately filtered through a 0.45 µm filter and further passed through a 3 kDa 
Microcon Ultracel filter (Millipore, Bedford, MA). The filtrate was transferred to 
siliconized tubes (VWR Scientific) and stored at -20°C until they were analyzed by 
liquid chromatography followed by tandem mass spectrometry (LC-MS/MS). The 
filtrates were resolved on an Agilent 1100 HPLC-Chip Cube Interface (Agilent 
Technologies). (Antwi et al., 2009) 
Construction of the ENCODE and Non-Exonic Databases 
The 1% of the human genome which the ENCODE consortium analyzed and 
found RNA from was bioinformatically translated into amino acid sequences into 6 
frames. Stop codons were used to define the endpoints of each peptide with a 
minimum length of 8 amino acids. This is the ENCODE database. The same 1% that 
is neither RefSeq nor ENCODE RNA were translated to form a non-exonic database. 
Both databases were created by Hojoon Lee. Figure 1 is an illustration of how the 
ENCODE database was generated. 
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Figure 1. Diagram of how the ENCODE database was bioinformatically constructed. 
The forward (top) and reverse (bottom) DNA strands were translated into amino acid 
sequences in 6 frames. Stop codons (X) were used to distinct one peptide from the 
adjacent ones. Frag 0, Frag 1, Frag 2, etc. represent different transcripts in all frames. 
The 1% of the human genome (ENCODE) was translated using this method. 
Peptide Synthesis 
Peptides were chemically synthesized at the proteomics core facility at the 
Arizona State University on a Milligen 9050 peptide synthesizer (Millipore, Bedford, 
MA). Mass spectrometric analysis was used to confirm the amino acid sequence. 
(Antwi, et al., 2009) 
mRNA Validation of Peptides 
1x10
7
 cells of each tumor cell line A549 (lung), DU145 (prostate), MCF-7 
(breast), and Panc-1 (pancreas) were harvested with Cellstripper (Mediatech Inc.). 
Total RNA was isolated from each tumor cell line and PBMCs with RNeasy Mini Kit 
(Qiagen). cDNA was synthesized using oligo-dT20 primers and reverse transcriptase 
III (Invitrogen) and treated with DNase to make sure only polyadenylated RNA were 
amplified. PCR was performed with primers flanking each peptide in the genomic 
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region. Transcripts of expected sizes were found for all peptides tested. DNA 
sequencing confirmed the sequences encoding each peptide. B-actin control was used 
to exclude the possibility of genomic DNA contamination. 
Polyclonal Antibody, Affinity Column 
Two peptides, HVTFILSNVII and PSYKPIPIPL, were chemically synthesized 
with a Cysteine on the N-terminus respectively. 2mg of each peptide was conjugated 
to KLH, a carrier protein, with the Imject Maleimide Activated mcKLH Kit (Thermo 
Scientific). Each KLH-conjugated peptide was injected into two rabbits on day 0, 
boosted 3 times from days 7-21, and anti-sera were collected in 28 days (Antibody 
China). Anti-sera were tested by ELISA. Anti-Met antibody was purchased from 
Abcam (ab10728). Anti-ST7 antibody was purchased from ProteinTech Group, Inc 
(11945-1-AP). 
In order to purify the polyclonal antibodies from rabbit anti-sera, peptide 
PSYKPIPIPL was immobilized on the SulfoLink Resin (Thermo Scientific). Rabbit 
anti-sera were incubated with the resin and peptide-specific antibodies bound to the 
peptides and were later eluted. The eluate was tested by ELISA to ensure activity and 
specificity. 
SDS-PAGE and Western Blotting 
Cell lysates from A549, DU145, MCF-7, Panc-1 and PBMC were generated 
using an established protocol (Abmayr, Yao, Parmely, & Workman, 2006). 20 μg of 
each cell lysate protein was loaded into the lanes of a 12% SDS-PAGE gel and 
electrophoresed under reducing conditions. The gel was transferred to PVDF 
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membrane, blocked with 5% nonfat powdered milk and probed with anti-ST7 and 
anti-PSYKPIPIPL rabbit polyclonal antibodies at concentrations of 0.41 μg/ml (1:500 
dilution) and 0.58 μg/ml for 1 hour, respectively. The blot was washed free of primary 
antibodies followed by the addition of goat anti-rabbit IgG coupled with horseradish 
peroxidase (HRP) (Jackson Immunolabs, Western Grove, PA) at 1:5000 dilution and 
incubation for 1 hour. After washing BCIP/NBT substrate (Pierce Chemical, Rockford, 
IL) was added and the blot was developed for 15 minutes to 1 hour at room 
temperature. 
 
RESULTS 
“Non-Exonic” Peptides Discovered by LC-MS/MS 
Acid elutions of each cell line (A549, BXPC-3, DU-145, MCF-7, Panc-1) and 
PBMC were analyzed using LC-MS/MS and the MS/MS data were analyzed. 241 
peptides were identified from searching the non-exonic database with mass spectra. 
They were denoted “non-exonic” peptides. Table 2 lists 12 such peptides which were 
further studied. 
Table 2 
List of “Non-Exonic” Peptides Discovered by LC-MS/MS 
Peptide sequence AA 
between 
stops 
Conservation Class Cell line 
HVTFILSNVII 38 0.349833398 Intronic_Distal PANC-1 (3X), 
A549 (1X) 
KTKIALSLSLPV 58 0.943750598 Intronic_Distal PANC-1 (3X) 
PSYKPIPIPL 82 0.05095702 Intronic_Distal PANC-1 (2X) 
IVSLEGKPL 22 0.00331329 Intronic_Distal MCF-7 (4X), 
BXPC-3 (2X) 
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APSRLTANSASRVH 36 0.013517592 Intronic_Distal MCF-7 (1X) 
CLPGSSNSPASASRVPGTTGA
RHHA 
96 0.003254897 Intronic_Proximal DU145 (1X) 
EFHNKKIL 15 5.80E-05 Intronic_Proximal PBMC (1X) 
ELPSLPPSLLLRLLSSPSSRVP 51 0.323618631 Intronic_Proximal DU145 (1X) 
FFYCSRVPQGLLLL 50 0.02791535 Intronic_Distal PANC-1 (1X) 
FITLTVRVLPF 41 0.049096215 Intronic_Distal PANC-1 (8X) 
LKWFQNVLT 20 0.005172044 Intronic_Proximal PANC-1 (1X) 
LSPSVCGPASKPFKI 77 0.097504436 Intronic_Distal PANC-1 (1X) 
Peptides ranging from 8 a.a. to 25 a.a. were identified from searching the 
non-exonic database. Some non-exonic peptides were found in intergenic regions (in 
between known genes); some were found in intronic regions (in between exons). 
Distal means the distance between the peptide and the nearest exon is >5kb and 
proximal means the distance is <5kb. A conservation score of 1.0 is 100% conserved 
in all species analyzed in the UCSC database. The cell lines in which these peptides 
were found are also listed. X means the number of times a peptide was identified in 
each acid elution by LC-MS/MS. The chromosomal and “gene” locations of each 
peptide were known because the peptide/protein databases were constructed from 
regions of the genome that the ENCODE consortium analyzed. As Figure 2 
demonstrates, 5 non-exonic peptides are located in the intronic region of a gene called 
ST7, a candidate tumor suppressor gene on human chromosome 7q31.2 (Zenklusen, 
Conti, & Green, 2001). ST7 has two established isoforms, a and b, as shown in Figure 
3 (Frazer, et al., 2003). Furthermore, peptide PSYKPIPIPL was found between exons 
1 and 2 of MET (Figure 4), KTKIALSLSLPV was found between exons 11 and 12 of 
CFTR (Figure 5), both of which are present on human chromosome 7q31.2, along 
with ST7 (Figure 6). This region has been reported for frequent loss of heterozygosity 
(LOH) of markers in malignant myeloid disorders as well as breast, prostate, ovarian, 
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colon, head and neck, gastric, pancreatic, and renal cell carcinomas, and it is 
suggested there is a tumor suppressor gene (TSG) present (Zenklusen, Weintraub, & 
Green, 1999). 
 
Figure 2. RefSeq Gene ST7, Homo Sapiens suppression of tumorigenicity 7. The 
human ST7 spans 16 exons. Peptides FFYCSRVPQGLLLL and HVTFILSNVII are 
located between exons 1 and 2 of ST7, both are distant from adjacent exons. Peptide 
LKWFQNVLT is located between exons 5 and 6, in a relatively small intron. Peptides 
FITLTVRVLPF and LSPSVCGPASKPFKI are located between exons 8 and 9. “()” 
indicates from which tumor cell line the peptide was found. 
 
Figure 3. The human ST7 locus on 7q31 has two splice variants (Frazer, K, et al). 
Isoform a is shorter in length than isoform b due to the fact that it is missing the 
alternatively spliced exon 7 and has a shorter length 3’-end exon. Both isoforms have 
their own NCBI access numbers, NM_018412 and NM_021908, respectively. 
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Figure 4. PSYKPIPIPL is located between exons 1 and 2 of MET, homo sapien met 
proto-oncogene (hepatocyte growth factor receptor). The PSYKPIPIPL peptide is 
proximal to exon 2. 
 
Figure 5. KTKIALSLSLPV is located between exons 11 and 12 of CFTR, homo 
sapien cystic fibrosis transmembrane conductance regulator (ATP-binding cassette 
sub-family C, member 7). 
Figure 6. Schematic representation of the positions and relative sizes of genes within 
the 7q31.2 on chromosome 7. A number of non-exonic peptides were found from 
intronic regions of genes on chromosome 7q31. 
mRNA Validation of Non-Exonic Peptides 
PCR was performed with primers flanking the genomic region containing each 
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peptide to test for transcripts in 4 tumor cell lines A549 (lung), DU145 (prostate), 
MCF-7 (breast), Panc-1 (pancreas) and PBMC. Β-actin control primers were used to 
exclude the possibility of any genomic DNA contamination. The expected PCR 
product of b-actin control is 189 bp, with a second band at 650 bp if there is any 
genomic contamination. Amplicons of expected sizes were observed by agarose gel 
electrophoresis. Each band was purified and sequenced. Sequencing validated that 
mRNA encoding these peptides were present in the tumor cell lines and in PBMC. 
The gel electrophoresis pictures of the PCR and sequencing trace files of peptides 
HVTFILSNVII, KTKIALSLPV, PSYKPIPIPL, IVSLEGKPL were included in Figure 
7.  
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Figure 7. mRNA validation of non-exonic peptides. A. HVTFILSNVII. B. 
KTKIALSLPV. C. PSYKPIPIPL. D. IVSLEGKPL. mRNA was harvested and treated 
with DNase from 4 tumor cell lines A549 (lung), DU145 (prostate), MCF-7 (breast), 
Panc-1 (pancreas) and PBMC. cDNA was synthesized using oligo-dT primers to 
ensure only poly(A) mRNA was replicated. Primers flanking the intronic region 
containing the peptide were used to amplify the transcript containing each sequence in 
the five cell types. Primers complementary to the 3’ end of exon 3 in b-actin and the 5’ 
end of exon 4 in b-actin were used to amplify the oligo-dT primed cDNA as a positive 
control and to asses if there was any genomic contamination. The expected PCR 
product is 189 bp, with a second band at 650 bp if there is any genomic contamination. 
For every cDNA template from cell lines, 2 PCRs were run. The first lane contains the 
PCR product of the oligo-dT primed cDNA and the primers flanking the peptide. The 
second contains the PCR product of the oligo-dT primed cDNA and b-actin primers. 
The PCR product of each peptide was sequenced, confirming the presence of codons 
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for each peptide within each intronic region.  
PCR with Exonic Primers 
We hypothesize that translation of “introns” might indicate that undiscovered 
splice variants exist for some genes, which means there might be undiscovered exons.  
If these undiscovered exons are expressed in frame with adjacent known exons, we 
can test our hypothesis. Thus, exonic primers were designed to test this hypothesis. 
Figure 8 shows the locations of exonic primers in relation to the intronic primers 
flanking the peptides that we used to validate the existence of mRNA for the peptides 
discovered by LC-MS/MS.  
 
Figure 8. Design of exonic and flanking primers and possible outcomes. As described 
in the methods section, primers flanking the peptides in the intronic regions were 
designed to find the peptide in primary transcripts. Furthermore, primers for adjacent 
exons were designed with the goal of finding additional product that contains any of 
the non-exonic peptides. Band 1 is the direct product of 2 exons, exon (n) and exon 
(n+1), spliced together as this is the known splicing product. If any peptide is from an 
alternative exon, an additional and larger band should be detected. The exception 
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would be if exon (n+1) was not spliced into the putative exon that the peptide is from. 
In Figure 9, PCR with exonic primers on HVTFILSNVII have 3 distinct bands. Bands 
a and b were purified and cloned into pCR2.1 TOPO vector (Invitrogen), and 
transformed into E. coli which were spread on LB plates with 50 ug/ml carbenicillin. 
Colonies were picked and expanded followed by PCR with M13 primers which would 
add an extra 201bp to each insert. Sequencing results revealed an extra exon, denoted 
exon 1a, which had previously been reported (Kimura et al., 2006). However, none of 
the PCR products (a, b or c) contained the peptide sequences. For the rest of the 
peptide candidates, a single band was obtained in each PCR product. Figure 10 is an 
example. The result indicates that the putative exon from which the peptide was 
detected is not spliced into the known exons, exon (n) or exon (n+1). It is inferred that 
the peptide is originated from an independent gene. This is the case for all the 
“non-exonic” peptides studied. 
 
Figure 9. Gel electrophoresis of PCR product with exonic and flanking primers on 
peptides HVTFILSNVII and KTKIALSLPV. mRNA from Panc-1 cell line was 
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harvested and treated with DNase. Lanes 1 and 3 are PCR products with exonic 
primers. Lanes 2 and 4 are PCR products with flanking primers. 3 bands showed up in 
lane 1. Subsequent cloning confirmed a small exon 1a between exons 1 and 2 in ST7, 
which had been discovered previously (Kimura, et al., 2006).  
 
Figure 10. Gel electrophoresis of PCR products with exonic primers of 3 peptides. 
mRNA was harvested and treated with DNase. For each peptide, PCR (single amino 
acid code in white at the top of the gel) with exonic primers were tested in PBMC and 
the tumor cell line for which the peptide was discovered by LC-MS/MS. For each 
reaction only one band was obtained that corresponded to the product of two known 
adjacent exons spliced together. 
“Baby-step” PCR 
In a strategy to find the entire transcript containing each peptide, “baby-step” 
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primers were designed as in Figure 11. The rationale for this was that trans-splicing 
might be occurring due to cryptic splice sites in the introns. Primers were designed on 
the intronic region upstream and downstream of peptides HVTFILSNVII and 
KTKIALSLPV, as shown in Figure 11. Expected products are around 1 kb for each 
primer pair, and the products overlap to make a complete connection of the entire 
transcripts. Oligo-dT primers were used to make cDNA from Panc-1 cell line to 
ensure only poly(A) RNA were amplified. Surprisingly, all primer pairs had 
amplification of the right size, which means almost 6 kb of mRNA were found 
containing the peptides. 2761 bp upstream and 3004 bp downstream of 
HVTFILSNVII were established (5799 bp total). Similarly, 2765 bp upstream and 
2932 bp downstream of KTKIALSLPV were established (5734 bp total). 
 
Figure 11. Design of “baby-step” primers covers ~6 kb of genomic sequence. Green 
primers were the initial flanking primers for detection of peptides. Although the 
peptide/protein database we built was based on ENCODE RNA, these results may 
lead to the conclusion that the peptides discovered by LC-MS/MS may have come 
from transcripts elsewhere in the genome and are not related to the genes from whose 
intronic regions they were discovered. 
Immunoprecipitation with Antibody 
Rabbit polyclonal antibodies were generated to two peptides, PSYKPIPIPL 
and HVTTFILSNVII. Due to the high hydrophobicity of HVTTFILSNVII, coupling 
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to KLH carrier was inefficient. For the same reason, HVTTFILSNVII was also a poor 
immunogen, and elicited only low titer antibodies. The rabbit sera against 
PSYKPIPIPL proved to be high titer, 1:25,600. PSYKPIPIPL peptide was coupled to 
a solid support via an N-terminal cysteine. Peptide-specific antibodies were purified 
from the high titer anti-PSYKPIPIPL rabbit antiserum using the peptide affinity 
column (Figure 12).  
Then anti-PSYKPIPIPL antibodies were used to make an affinity column 
using hydrazide chemistry to link oxidized carbohydrate groups on the antibody to a 
solid support (Thermo Scientific). Once the “anti-PSYK” antibody column was 
constructed and tested using PSYKPIPIPL linked to bovine serum albumin (BSA), 
cell lysates from Panc-1 cell line from which PSYKPIPIPL was originally discovered 
was run through the column. The eluate was run on a SDS-PAGE gel, but no band 
was observed. Western blotting with commercial anti-ST7 antibody only detected the 
native form of ST7 (63 kDa) in the 4 tumor cell lines tested, A549, DU145, MCF-7 
and Panc-1 (Figure 13 A). Western blotting with affinity-purified anti-PSYKPIPIPL 
antibody did not show any specific band on the membrane (Figure 13 B), which may 
be due to the low abundance of the peptide in the cell lysate samples, or the resolution 
limit of western blotting. 
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Figure 12. ELISA on rabbit anti-sera. A. Anti-HVTFILSNVII-KLH anti-sera had only 
KLH-specific antibodies (Ab China). B. Anti-PSYKPIPIPL antibodies were 
successfully purified using peptide column. ELISA on anti serum and flow-through 
both started at 1:100 dilution and ELISA on eluted antibodies started at 1μg/ml and 
2-fold dilution was performed. C. Anti-PSYKPIPIPL antibodies were tested for 
cross-specificity for HVTFILSNVII (starting at 1μg/ml and 2-fold dilution), and 
showed no such activity. 
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Figure 13. Western blotting with anti-ST7 and anti-PSYKPIPIPL antibodies. A. 
Western blotting for the detection of possible splicing variants of ST7 with 
commercial anti-ST7 antibody. Anti-ST7 rabbit polyclonal antibody was incubated 
with PVDF membrane blotted with cell lysate made from 1x10
7
 cells from 4 human 
tumor cell lines: A549, DU145, MCF-7, Panc-1 and healthy donor PBMC. 20 μg of 
cell lysate protein was added to each lane followed by SDS-PAGE as described in 
Methods section. The protein ladder used was SeeBlue Plus 2 Pre-Stained Standard 
(Invitrogen, CA). The known size of ST7 is 63 kDa which was detected. B. Western 
blotting with affinity-purified anti-PSYKPIPIPL antibody. No specific band appeared 
on the membrane suggesting that the amount of the product including peptide 
PSYKPIPIPL may be below the detection limit of western blotting, or the size of the 
product is too small to be resolved on a western blotting. 
DISCUSSION 
The ENCODE pilot project has provided with us a rich source of functional 
information on the human genome. One remarkable discovery is the generation of 
numerous intercalated transcripts spanning the majority of the genome. However, the 
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biological functions of these transcripts are not known. The ENCODE consortium 
proposed that some of them were regulatory elements. Our studies suggest that some 
of the ENCODE RNA is translated into protein and peptides. As is known today, 
current gene annotation and gene prediction is not 100% accurate. We suggest the 
peptides we found in tumor cell lines serve some function, whether as peptides, or are 
fragments of undescribed splice variants. Although the functions of the peptides are 
unknown at the moment, a recent publication in Science indicates that translation of 
peptides impart a phenotype in Drosophila. Dr. Kageyama and his collaborators 
demonstrated that during Drosophila embryogenesis, peptides (11-32 amino acids) 
provided a strict temporal control of the transcriptional program of epidermal 
morphogenesis by modifying a transcription factor (Kondo et al., 2010). Other studies 
indicate that a fraction of ncRNAs with short open reading frames (ORFs) potentially 
encodes peptides and they may play key roles in cell signaling and other processes 
(Amaral, et al., 2008; Frith et al., 2006). 
Due to the 3 kDa filtration of acid elutions methods, the peptides we 
discovered are only 8 to 25 in length. We were able to PCR-amplify polyadenylated 
mRNA that contained the peptide sequences we detected by LC-MS/MS and confirm 
the presence of the peptide by DNA sequence analysis. Initially, we hypothesized the 
intronic peptides came from different splice variants. To prove this hypothesis, PCR 
was performed using primers in exons that flanked the intronic peptide. The results 
suggestsed the peptide had no link to known exons, because we never observed a 
product containing flanking exons plus an exon containing the target peptide. This 
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negative result, along with the large size of the intron, lead us to hypothesize that the 
peptides may come from independent genes, which means there could be a gene 
within a gene. Supporting this hypothesis is the data indicating that Western blotting 
using commercial antibodies against ST7 and MET did not detect any other 
spliceoform of either ST7 or MET. However, the inconclusive result from 5' RACE 
and 3' RACE did not solve the puzzle, and Northern blots were not successful. 
Moreover, “baby-step” PCR revealed there were nearly 6 kb continuous mRNA 
present between both ST7 and MET, which is already larger than any known exon. 
One possibility is that pre-spliceosome was amplified which explains why I had a 
6kb-mRNA. Despite the difficulties encountered in the latter stages of this project, we 
showed that peptides are produced from large introns in 5 different human tumor cell 
lines and human PBMC. We were able to detect the peptides directly from cell lysate 
by mass spectrometry. We validated polyadenylated RNAs coding for these peptides. 
Our results from both “baby-step” PCRs and western blots suggest that these peptides 
may come from independent genes that locate in the intronic regions of other genes. 
However, there are many questions that remain to be answered. 
Another question to answer is how the mRNAs got translated. All peptide 
sequences and contexts were examined. There were no close start codons upstream in 
frame with the peptides. No traditional splicing donor and acceptor sites were found. 
More interestingly and mysteriously, some of the peptides had stop codons in frame 
not far upstream, especially the HVTFILSNVII peptide, which has a stop codon right 
ahead of it. The stop codon got skipped for mechanisms unknown to us yet. We hope 
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with the inventions of new technologies we can examine these non-exonic peptides 
further. 
Though many questions await to be answered, our findings have significant 
implications. Conservation of many of those non-exonic peptides (Table 2) suggests 
that evolution selected to preserve the ability to transcribe and translate the 
“non-coding” regions of DNA. The most difficult future of this project will be to 
elucidate the biological functions of those small peptides. We anticipate our 
preliminary results will lead to the study and findings of novel transcriptional and 
translational mechanisms. The elevated transcription and translation activity of the 
genome may give us biomarkers for early diagnosis and potential drug targets. 
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